510(k) device
Beacon Tissue Marker (SE)
Scion Medical Technologies, LLC · Marker, Radiographic, Implantable (NEU, Class II) · First FDA decision May 8, 2013, newest Dec 17, 2015Breast cancer
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
2
510(k) pathway
Device trials
4
Naming "Beacon Tissue"
MAUDE reports
3
Brand "Beacon Tissue", since 2015
PubMed studies
0
Mentioning "Beacon Tissue"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Beacon Tissue Marker (SE)
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 2 of 2 decisions filed under this name.
K153189 · Decided Dec 17, 2015 · 44 days after receipt
Device type: Marker, Radiographic, Implantable (NEU) · General & Plastic Surgery
- BEACON TISSUE MARKER510(k)
K130763 · Decided May 8, 2013 · 49 days after receipt
Device type: Marker, Radiographic, Implantable (NEU) · General & Plastic Surgery
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "Beacon Tissue", any status and sponsor, newest update first.
Thomas Jefferson UniversityAcademic, hospital or other
NCT02872831 · 0 participants · Start Jul 2016 · Primary completion Jul 2017
Device: 22G SharkCore™ needle; 22G BNX EUS-FNA Needle · For: Pancreatic Cancer; Lymphadenopathy; Cholangiocarcinoma
Sites: Philadelphia, Pennsylvania
Newcastle-upon-Tyne Hospitals NHS TrustAcademic, hospital or other
NCT03532347 · 108 participants · Start May 22, 2017 · Primary completion May 4, 2018
Device: EUS-FNA needle (Beacon) · For: Pancreas Cancer; Pancreas Neoplasm, Benign; Chronic Pancreatitis and 1 more
Sites: Newcastle, United Kingdom
Istituto Clinico HumanitasAcademic, hospital or other
NCT02946840 · 100 participants · Start Aug 2016 · Primary completion May 2017
Device: FNA with 25 G Beacon needle · For: Pancreatic Masses
Sites: Rozzano, Italy
1 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Beacon Tissue", and for the whole product code for context.
This brand
3 reports: 1 malfunction, 0 injury, 0 death
Whole product code NEU
1,678 reports: 518 malfunction, 1,149 injury, 1 death
Newest reports for this brand
- CASSI BEACON TISSUE MARKERNot stated
SCION MEDICAL TECHNOLOGIES LLC
3009545273-2015-00001 · Received Aug 5, 2015 · Event dated Jan 19, 2015
Device type: Marker, Radiographic, Implantable (NEU)
Device problem as coded: Insufficient Device Problem Information
Patient problem as coded: Hypersensitivity/Allergic reaction; Itching Sensation; Pain
- CASSI BEACON TISSUE MARKERMalfunction
MW5044526 · Received Jul 16, 2015 · Event dated Nov 26, 2014
Device type: Marker, Radiographic, Implantable (NEU)
Device problem as coded: Adverse Event Without Identified Device or Use Problem
Patient problem as coded: Dyspnea; Pain; Rash; Anxiety
- CASSI BEACON TISSUE MARKERNot stated
4808044 · Received May 29, 2015 · Event dated Nov 26, 2014
Device type: Marker, Radiographic, Implantable (NEU)
Device problem as coded: Appropriate Device Problem Term/Code Not Available
Patient problem as coded: Allergic reaction; Itching Sensation; Pain
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "Beacon Tissue"[tiab]. The summary above synthesizes these.
No PubMed record mentions this device by name.
Other devices of this type
Also filed under product code NEU.
- HydroMARK Breast Biopsy Site MarkerDevicor Medical Products, Inc. · 510(k) 2022
- MOLLI 2 SystemMolli Surgical, Inc. · 510(k) 2024
- HydroMARK Plus Breast Biopsy Site Marker (Dragonfly Shape)Devicor Medical Products, Inc. · 510(k) 2026
- UltraCor Twirl Breast Tissue MarkerBard Peripheral Vascular, Inc. · 510(k) 2025
- RFID Localization SystemHealth Beacons, Inc. · 510(k) 2020
- Cianna Medical SAVI Scout Reflector and SAVI Scout SystemCianna Medical, Inc. · 510(k) 2018
- Biopsy Sciences, Inc. Hydromark Brest Biosy Site MarkerBiopsy Sciences, LLC · 510(k) 2012
- Securmark Biopsy Site Marking SystemSuros Surgical Systems, Inc. A Hologic Company · 510(k) 2010
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.